These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30029468)

  • 1. (-)-Homosalinosporamide A and Its Mode of Proteasome Inhibition: An X-ray Crystallographic Study.
    Groll M; Nguyen H; Vellalath S; Romo D
    Mar Drugs; 2018 Jul; 16(7):. PubMed ID: 30029468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinspired total synthesis and human proteasome inhibitory activity of (-)-salinosporamide A, (-)-homosalinosporamide A, and derivatives obtained via organonucleophile promoted bis-cyclizations.
    Nguyen H; Ma G; Gladysheva T; Fremgen T; Romo D
    J Org Chem; 2011 Jan; 76(1):2-12. PubMed ID: 21047113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysing properties of proteasome inhibitors using kinetic and X-ray crystallographic studies.
    Gallastegui N; Groll M
    Methods Mol Biol; 2012; 832():373-90. PubMed ID: 22350899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salinosporamides D-J from the marine actinomycete Salinispora tropica, bromosalinosporamide, and thioester derivatives are potent inhibitors of the 20S proteasome.
    Reed KA; Manam RR; Mitchell SS; Xu J; Teisan S; Chao TH; Deyanat-Yazdi G; Neuteboom ST; Lam KS; Potts BC
    J Nat Prod; 2007 Feb; 70(2):269-76. PubMed ID: 17243724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural analysis of spiro beta-lactone proteasome inhibitors.
    Groll M; Balskus EP; Jacobsen EN
    J Am Chem Soc; 2008 Nov; 130(45):14981-3. PubMed ID: 18928262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and evaluation of cystargolide-based β-lactones as potent proteasome inhibitors.
    Niroula D; Hallada LP; Le Chapelain C; Ganegamage SK; Dotson D; Rogelj S; Groll M; Tello-Aburto R
    Eur J Med Chem; 2018 Sep; 157():962-977. PubMed ID: 30165344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent proteasome inhibitors derived from the unnatural cis-cyclopropane isomer of Belactosin A: synthesis, biological activity, and mode of action.
    Kawamura S; Unno Y; List A; Mizuno A; Tanaka M; Sasaki T; Arisawa M; Asai A; Groll M; Shuto S
    J Med Chem; 2013 May; 56(9):3689-700. PubMed ID: 23547757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An efficient, stereocontrolled synthesis of a potent omuralide-salinosporin hybrid for selective proteasome inhibition.
    Reddy LR; Fournier JF; Subba Reddy BV; Corey EJ
    J Am Chem Soc; 2005 Jun; 127(25):8974-6. PubMed ID: 15969573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Minimal β-Lactone Fragment for Selective β5c or β5i Proteasome Inhibitors.
    Groll M; Korotkov VS; Huber EM; de Meijere A; Ludwig A
    Angew Chem Int Ed Engl; 2015 Jun; 54(27):7810-4. PubMed ID: 25973989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimerized linear mimics of a natural cyclopeptide (TMC-95A) are potent noncovalent inhibitors of the eukaryotic 20S proteasome.
    Desvergne A; Genin E; Maréchal X; Gallastegui N; Dufau L; Richy N; Groll M; Vidal J; Reboud-Ravaux M
    J Med Chem; 2013 Apr; 56(8):3367-78. PubMed ID: 23540790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Snapshots of the fluorosalinosporamide/20S complex offer mechanistic insights for fine tuning proteasome inhibition.
    Groll M; McArthur KA; Macherla VR; Manam RR; Potts BC
    J Med Chem; 2009 Sep; 52(17):5420-8. PubMed ID: 19678642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A concise and straightforward total synthesis of (+/-)-salinosporamide A, based on a biosynthesis model.
    Mulholland NP; Pattenden G; Walters IA
    Org Biomol Chem; 2008 Aug; 6(15):2782-9. PubMed ID: 18633536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leaving groups prolong the duration of 20S proteasome inhibition and enhance the potency of salinosporamides.
    Manam RR; McArthur KA; Chao TH; Weiss J; Ali JA; Palombella VJ; Groll M; Lloyd GK; Palladino MA; Neuteboom ST; Macherla VR; Potts BC
    J Med Chem; 2008 Nov; 51(21):6711-24. PubMed ID: 18939815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients.
    Levin N; Spencer A; Harrison SJ; Chauhan D; Burrows FJ; Anderson KC; Reich SD; Richardson PG; Trikha M
    Br J Haematol; 2016 Sep; 174(5):711-20. PubMed ID: 27161872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of salinosporamide A and its analogs as 20S proteasome inhibitors and SAR summarization.
    Ma Y; Qu L; Liu Z; Zhang L; Yang Z; Zhang L
    Curr Top Med Chem; 2011 Dec; 11(23):2906-22. PubMed ID: 21824108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total synthesis of (-)-salinosporamide A.
    Satoh N; Yokoshima S; Fukuyama T
    Org Lett; 2011 Jun; 13(12):3028-31. PubMed ID: 21591679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanocidal activity of β-lactone-γ-lactam proteasome inhibitors.
    Steverding D; Wang X; Potts BC; Palladino MA
    Planta Med; 2012 Jan; 78(2):131-4. PubMed ID: 22034066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial self-resistance to the natural proteasome inhibitor salinosporamide A.
    Kale AJ; McGlinchey RP; Lechner A; Moore BS
    ACS Chem Biol; 2011 Nov; 6(11):1257-64. PubMed ID: 21882868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding mode of TMC-95A analogues to eukaryotic 20S proteasome.
    Kaiser M; Groll M; Siciliano C; Assfalg-Machleidt I; Weyher E; Kohno J; Milbradt AG; Renner C; Huber R; Moroder L
    Chembiochem; 2004 Sep; 5(9):1256-66. PubMed ID: 15368577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (S)-4-Trimethylsilyl-3-butyn-2-ol as an auxiliary for stereocontrolled synthesis of salinosporamide analogs with modifications at positions C2 and C5.
    Blasdel LK; Lee D; Sun B; Myers AG
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6905-10. PubMed ID: 24269479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.